KEGG   VARIANT: 2263v2
Entry
2263v2                      Variant                                
Name
FGFR2 fusion
Gene
FGFR2  fibroblast growth factor receptor 2 [KO:K05093]
Organism
hsa_var Human gene variants (Homo sapiens)
Variation
FGFR2-BICC1 fusion, translocation t(10;10)(q21;q26)
Variation
FGFR2-CASP7 fusion, translocation t(10;10)(q25;q26)
Drug target
Erdafitinib: D10927<JP/US>
Futibatinib: D11725<JP/US>
Infigratinib (DG03062): D11611
Pemigatinib: D11417<JP/US>
Tasurgratinib (DG03234): D12405<JP>
Reference
PMID:31544541
  Authors
Marandino L, Raggi D, Giannatempo P, Fare E, Necchi A
  Title
Erdafitinib for the treatment of urothelial cancer.
  Journal
Expert Rev Anticancer Ther 19:835-846 (2019)
DOI:10.1080/14737140.2019.1671190
Reference
PMID:31030123
  Authors
Nadal R, Bellmunt J
  Title
Management of metastatic bladder cancer.
  Journal
Cancer Treat Rev 76:10-21 (2019)
DOI:10.1016/j.ctrv.2019.04.002
LinkDB

DBGET integrated database retrieval system